Search Results - "BARBULLUSHI, MYFTAR"

Refine Results
  1. 1
  2. 2
  3. 3

    The potential effect of cardiac function on pulmonary hypertension, other risk factors, and its impact on survival in dialysis patients by Rroji, Merita, Cafka, Majlinda, Seferi, Saimir, Seiti, Joana, Barbullushi, Myftar, Goda, Artan

    Published in International urology and nephrology (01-02-2021)
    “…Introduction Pulmonary hypertension (PH) is a recently recognized as a complication of chronic kidney disease and end-stage renal disease. The pathogenesis of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The new Era of non-Steroidal Mineralocorticoid Antagonists in Treating Heart Failure in Diabetic Kidney Disease Patients by Hasani, Eqerem, Rroji, Merita, Barbullushi, Myftar

    “…Inappropriate activation of the mineralocorticoid receptor (MR) plays a significant role in developing hypertension, the development of cardiac pathological…”
    Get full text
    Journal Article
  6. 6

    Therapeutic monitoring of mycophenolic acid in renal transplanted patients by a validated HPLC method by Kolaci, Mikaela, Deda, Leonard, Idrizi, Alma, Barbullushi, Myftar, Thereska, Dariel

    Published in Folia Medica (31-10-2021)
    “…Introduction: Mycophenolate mofetil and its active metabolite mycophenolic acid are routinely used as immunosuppressant drugs in solid organ transplantation in…”
    Get full text
    Journal Article
  7. 7

    An Overview of Treatment of Crush Syndrome by Rroji, Merita, Seferi, Saimir, Barbullushi, Myftar

    “…Natural mass disasters directly or indirectly affect huge populations, who need basic infrastructural help and assistance to survive. However, despite the…”
    Get full text
    Journal Article
  8. 8

    Familial hemolytic uremic syndrome with occurrence in the postpartum period by Barbullushi, Myftar, Idrizi, Alma, Goce, Spasovski

    “…The hemolytic uremic syndrome (HUS) is a heterogeneous group of similar entities characterized by microangiopathic hemolytic anemia, thrombocytopenia, and…”
    Get full text
    Journal Article
  9. 9

    Impact of liver cysts in progression of polycystic kidney disease by Idrizi, Alma, Barbullushi, Myftar, Beqiri, Arben, Hoxha, Liri, Koroshi, Alketa, Spahia, Nereida, Gjata, Margarita, Xhaferri, Xhoana, Bajrami, Valbona, Thereska, Nestor

    Published in Central European journal of medicine (01-06-2013)
    “…Introduction Liver involvement is the most frequent extrarenal manifestation in autosomal dominant polycystic kidney disease (ADPKD). We studied the impact of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Prevalence of nephrolithiasis in polycystic kidney disease by Idrizi, Alma, Barbullushi, Myftar, Gjata, Margarita, Koroshi, Alketa, Roshi, Enver, Backa, Teuta, Kodra, Sulejman, Thereska, Nestor

    Published in Central European journal of medicine (01-08-2011)
    “…We aim to define the prevalence of nephrolithiasis, the impact of anatomic and metabolic factors to stone formation and prognosis of patients with autosomal…”
    Get full text
    Journal Article
  13. 13

    Sodium and water dynamics in the progression of chronic kidney disease: mechanisms and clinical significance by Spahia, Nereida, Rroji, Merita, Idrizi, Alma, Spasovski, Goce, Barbullushi, Myftar

    Published in International urology and nephrology (01-06-2024)
    “…Aim Lifestyle modifications can postpone the progression of chronic kidney disease toward its terminal stage. This mini-review aims to explore the impact of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    P1207ANALYSIS OF OUTCOME AND FACTORS ASSOCIATED WITH MAINTENANCE OF PERITONEAL DIALYSIS by Rroji (Molla), Merita, Seferi, Saimir, Shehaj, Larisa, Barbullushi, Myftar

    Published in Nephrology, dialysis, transplantation (01-06-2020)
    “…Abstract Background and Aims Peritoneal dialysis (PD) is generally associated with a good survival rate and with great preservation of residual renal function…”
    Get full text
    Journal Article
  20. 20